Pharmachem Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- Pharmachem Laboratories's estimated annual revenue is currently $44.8M per year.
- Pharmachem Laboratories's estimated revenue per employee is $297,000
Employee Data
- Pharmachem Laboratories has 151 Employees.
- Pharmachem Laboratories grew their employee count by 6% last year.
Pharmachem Laboratories's People
Name | Title | Email/Phone |
---|---|---|
1 | Director R&D | Reveal Email/Phone |
2 | general manager | Reveal Email/Phone |
3 | Transportation Manager | Reveal Email/Phone |
4 | QA Analytical/Document Creation | Reveal Email/Phone |
5 | Quality control | Reveal Email/Phone |
6 | Production Assistant | Reveal Email/Phone |
7 | Sr. Administrative Assistant | Reveal Email/Phone |
Pharmachem Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $127.4M | 634 | 19% | N/A | N/A |
What Is Pharmachem Laboratories?
Pharmachem Laboratories, Inc., is a leading manufacturer and supplier of value-added nutritional ingredients and bulk raw materials. We offer an exclusive list of trademarks and catalogue of products, as well as custom-manufacturing, and research and development services. Think of Pharmachem for all your nutritional ingredient needs.
keywords:N/AN/A
Total Funding
151
Number of Employees
$44.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pharmachem Laboratories News
ADM; BASF; Pharmachem Laboratories; Cargill; HSF Biotech. The market is categorized in the study based on. Soybean Oil Derived; Rapeseed Oil...
BASF; Pharmachem Laboratories; Cargill; HSF Biotech. The product may be classified into the following market segments based on its type: Soybean...
... Aloecorp Inc., Aloe Vera Australia, Natural Aloe Costa Rica S.A., Pharmachem Laboratories Inc., Terry Laboratories Inc.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 155 | 27% | N/A |
#2 | $42.3M | 183 | 13% | N/A |
#3 | N/A | 192 | 28% | N/A |
#4 | $59.7M | 201 | 1% | N/A |
#5 | $35M | 209 | -1% | N/A |